Kobayashi Pharmaceutical Co., Ltd. (FRA:KOY)

Germany flag Germany · Delayed Price · Currency is EUR
28.60
+0.20 (0.70%)
At close: Oct 20, 2025
0.70%
Market Cap2.24B
Revenue (ttm)953.05M
Net Income (ttm)69.63M
Shares Outn/a
EPS (ttm)0.94
PE Ratio32.19
Forward PEn/a
Dividend0.62 (2.16%)
Ex-Dividend DateJun 27, 2025
Volumen/a
Average Volume13
Open28.60
Previous Close28.40
Day's Range28.60 - 28.60
52-Week Range27.60 - 39.20
Betan/a
RSI48.78
Earnings DateNov 11, 2025

About Kobayashi Pharmaceutical

Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the manufacture and sale of OTC pharmaceuticals, guasi-drugs, deodorizing air fresheners, and sanitary products in Japan and internationally. The company offers Ammeltz, an anti-inflammatory pain relief medicine; Dent, an effervescent denture cleaning agent; Ekitai Bluelet Okudake, a toilet bowl cleaner; Naicitol, a Chinese medicine; BreathCare, an oral breath freshener capsule; Netsusama sheet, a cooling gel sheet; and deodorizing air freshener, lens cleaner, coolin... [Read more]

Industry Pharmaceutical Preparations
Founded 1886
Employees 3,615
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol KOY
Full Company Profile

Financial Performance

In 2024, Kobayashi Pharmaceutical's revenue was 165.60 billion, a decrease of -4.53% compared to the previous year's 173.46 billion. Earnings were 10.07 billion, a decrease of -50.50%.

Financial numbers in JPY Financial Statements

News

There is no news available yet.